packageMavorixafor

mavorixafor

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Mavorixafor is an immunostimulant medicine used for primary immunodeficiency diseases. It is approved and authorised in the European Union, and is also being investigated for other uses.

Summary written by glm-5.3-flash from Wikidata Q27074430 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:mavorixafor
ATC codes:L03AX24, Not yet assigned
DrugBank:DB05501
PubChem CID:11256587
ChEBI:138865
Wikidata:Q27074430
formula:C21H27N5
molar mass:349.482 g/mol (PubChem CID 11256587)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown